Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Completed 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1CNS 1

Conditions

Pain 2Marijuana Abuse 2Recurrence 1Parasomnias 1Nausea 1Marijuana Use 1Glioblastoma 1Brain Neoplasms 1Anxiety Disorders 1Advanced Malignant Solid Tumor 1

Interventions

pembrolizumab 1254Specimen Handling 869Carboplatin 818Magnetic Resonance Spectroscopy 804Cyclophosphamide 795Cisplatin 716Nivolumab 648Paclitaxel 623Radiotherapy 567Gemcitabine 565Biopsy 529Bevacizumab 468Dexamethasone 434fludarabine 404Docetaxel 373venetoclax 366Oxaliplatin 362Capecitabine 353Fluorouracil 352atezolizumab 341Rituximab 327durvalumab 326Doxorubicin 313Radiosurgery 306Pemetrexed 303Drug Therapy 295Standard of Care 292Ipilimumab 290Etoposide 280Radiation 278

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × nabiximols × 1 year × Clear all
NCT05629702 2026-05-05

ARISTOCRAT

University of Birmingham

Phase 2 Recruiting
120 enrolled
CNS

Brain Neoplasms, Marijuana Abuse, Glioblastoma, Recurrence

NCT07459920 2026-03-10

CAPTURE

National Cancer Institute, Naples

Phase 2 Not yet recruiting
156 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumor

NCT04827992 2025-11-05

Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain

Massachusetts General Hospital

Phase NA Completed
87 enrolled

Marijuana Use, Marijuana Abuse, Pain

NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed
91 enrolled

Anxiety Disorders, Nausea, Pain, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡